Android app Apple app link

CRISPR Therapeutics AG (CRSP) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$36.99

south_east
-$1.05 (-2.76%)
Day's range
$36.93
Day's range
$38.15

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
02/03/2025 H.C. Wainwright Mitchell Kapoor $65.00 $40.00   62.5%
11/06/2024 Oppenheimer Jay Olson $95.00 $49.51   91.88%
11/05/2024 Leerink Partners Rick Bienkowski $67.00 $50.36   33.04%
08/12/2024 Truist Financial Joon Lee $100.00 $46.55   114.82%
08/06/2024 Needham Gil Blum $84.00 $50.11   67.63%
08/06/2024 Stifel Nicolaus Benjamin Burnett $59.00 $50.01   17.98%
08/06/2024 RBC Capital Luca Issi $60.00 $50.13   19.7%
05/09/2024 Robert W. Baird Jack Allen $52.00 $53.29   -2.42%
08/09/2022 Chardan Capital Geulah Livshits $79.30 $81.39   -2.57%
06/17/2022 BMO Capital Kostas Biliouris $98.00 $70.73   38.56%
02/15/2022 Needham Gil Blum $170.00 $61.97   174.33%
02/14/2022 Leerink Partners Rick Bienkowski $120.00 $60.97   96.82%
01/06/2022 Wells Fargo Yanan Zhu $105.00 $67.66   55.19%
11/03/2021 Oppenheimer Jay Olson $172.00 $93.00   84.95%
10/11/2021 Piper Sandler Edward Tenthoff $180.00 $102.59   75.46%
08/15/2021 Canaccord Genuity Arlinda Lee $160.00 $122.55   30.56%
06/10/2021 Roth Capital Anthony Butler $171.00 $127.00   34.65%
04/20/2021 Jefferies Maury Raycroft $172.00 $124.93   37.68%

CRISPR Therapeutics AG FAQ's

CRISPR Therapeutics AG has been rated by research analysts at H.C. Wainwright, Oppenheimer, Leerink Partners, Truist Financial, Needham, Stifel Nicolaus in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.